Quantum-Si (NASDAQ:QSI) Trading Down 5.2% – Should You Sell?

Quantum-Si Incorporated (NASDAQ:QSI) shares traded down 5.2% during mid-day trading on Tuesday . The stock traded as low as $0.9353 and last traded at $0.9388. 3,528,987 shares were traded during mid-day trading, a decline of 25% from the average session volume of 4,678,401 shares. The stock had previously closed at $0.9906.

Analyst Ratings Changes

Several analysts recently commented on QSI shares. Weiss Ratings restated a “sell (d-)” rating on shares of Quantum-Si in a research report on Monday, December 29th. Canaccord Genuity Group lowered their target price on shares of Quantum-Si from $2.00 to $1.50 and set a “hold” rating on the stock in a research note on Monday, December 22nd. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $3.55.

Quantum-Si Trading Down 5.2%

The stock has a market cap of $202.30 million, a price-to-earnings ratio of -1.40 and a beta of 2.98. The firm’s 50-day moving average is $1.19 and its two-hundred day moving average is $1.40.

Insiders Place Their Bets

In other Quantum-Si news, insider John S. Vieceli sold 21,927 shares of Quantum-Si stock in a transaction on Monday, December 22nd. The shares were sold at an average price of $1.28, for a total transaction of $28,066.56. Following the sale, the insider owned 800,973 shares of the company’s stock, valued at $1,025,245.44. The trade was a 2.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jeffrey Alan Hawkins sold 23,707 shares of the stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $1.28, for a total transaction of $30,344.96. Following the completion of the sale, the chief executive officer owned 2,578,018 shares of the company’s stock, valued at $3,299,863.04. This trade represents a 0.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 54,261 shares of company stock worth $69,454 in the last 90 days. 22.95% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Quantum-Si

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Prudential Financial Inc. acquired a new position in Quantum-Si during the second quarter worth $25,000. Curbstone Financial Management Corp acquired a new stake in Quantum-Si during the fourth quarter worth about $26,000. Capital Investment Advisory Services LLC boosted its holdings in Quantum-Si by 100.0% in the 3rd quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock valued at $28,000 after purchasing an additional 10,000 shares during the last quarter. Leonteq Securities AG purchased a new stake in shares of Quantum-Si in the 4th quarter valued at approximately $28,000. Finally, Elite Life Management LLC acquired a new stake in shares of Quantum-Si during the 3rd quarter worth approximately $29,000. Institutional investors and hedge funds own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.